Erratum: (Arteriosclerosis, Thrombosis, and Vascular Biology (2014) 34 (724-736) DOI: 10.1161/ATVBAHA.113.302642);Has our understanding of calcification in human coronary atherosclerosis progressed?

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 34, Issue 4, 2014, Pages 724-736

  Otsuka, Fumiyuki ^a   Sakakura, Kenichi ^a   Yahagi, Kazuyuki ^a   Joner, Michael ^a   Virmani, Renu ^a  

^a CVPATH INSTITUTE   (United States)

Author keywords

coronary artery disease; pathology; vascular calcification

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE SIALOPROTEIN; CALCIUM; CONJUGATED ESTROGEN; EPOXIDE HYDROLASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OSTEOCALCIN; OSTEONECTIN; OSTEOPONTIN; OSTEOPROTEGERIN; PROTEOGLYCAN; TRANSCRIPTION FACTOR RUNX2;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; AUTOPSY; BASEMENT MEMBRANE; BONE DENSITY; BONE MATRIX; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CHRONIC KIDNEY FAILURE; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY THROMBOSIS; DIABETES MELLITUS; DISEASE COURSE; DNA POLYMORPHISM; ELASTIC FIBER; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FIBRIN DEPOSITION; FIBROATHEROMA; FOLLOW UP; GENE EXPRESSION; GENETIC PREDISPOSITION; HEART INFARCTION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INCIDENCE; INTRAVASCULAR ULTRASOUND; LEG AMPUTATION; LIPID STORAGE; MACROPHAGE; NONHUMAN; OSSIFICATION; PERIPHERAL VASCULAR DISEASE; PHENOTYPE; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; VASCULAR CAPACITY;

CORONARY ARTERY DISEASE; PATHOLOGY; VASCULAR CALCIFICATION;

ANIMALS; APOPTOSIS; CONTINENTAL POPULATION GROUPS; CORONARY ARTERY DISEASE; CORONARY VESSELS; DISEASE PROGRESSION; FEMALE; FIBROSIS; HUMANS; MACROPHAGES; MALE; NECROSIS; PLAQUE, ATHEROSCLEROTIC; PROGNOSIS; RISK FACTORS; RUPTURE, SPONTANEOUS; SEX FACTORS; VASCULAR CALCIFICATION;

EID: 84897395443     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATV.0000000000000008     Document Type: Erratum

References (73)

1. Rader DJ, Daugherty A. Translating molecular discoveries into new therapies for atherosclerosis. Nature. 2008;451:904-913.
2. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
3. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. 1999;353:89-92.
4. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classifca-tion scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262-1275.
5. Velican C. A dissecting view on the role of the fatty streak in the patho-genesis of human atherosclerosis: culprit or bystander? Med Interne. 1981;19:321-337.
6. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW. A defnition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994;89:2462-2478.
7. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A defnition of advanced types of atherosclerotic lesions and a histological classifcation of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995;92:1355-1374.
8. Kolodgie FD, Burke AP, Farb A, Gold HK, Yuan J, Narula J, Finn AV, Virmani R. The thin-cap fbroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes. Curr Opin Cardiol. 2001;16:285-292.
9. Kolodgie FD, Burke AP, Farb A, Weber DK, Kutys R, Wight TN, Virmani R. Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thromb Vasc Biol. 2002;22:1642-1648.
10. Burke AP, Kolodgie FD, Farb A, Weber DK, Malcom GT, Smialek J, Virmani R. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation. 2001;103:934-940.
11. Kockx MM, De Meyer GR, Muhring J, Jacob W, Bult H, Herman AG. Apoptosis and related proteins in different stages of human atherosclerotic plaques. Circulation. 1998;97:2307-2315.
12. Vengrenyuk Y, Carlier S, Xanthos S, Cardoso L, Ganatos P, Virmani R, Einav S, Gilchrist L, Weinbaum S. A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifcations in thin fbrous caps. Proc Natl Acad Sci USA. 2006;103:14678-14683.
13. Kelly-Arnold A, Maldonado N, Laudier D, Aikawa E, Cardoso L, Weinbaum S. Revised microcalcifcation hypothesis for fbrous cap rupture in human coronary arteries. Proc Natl Acad Sci USA. 2013;110:10741-10746.
14. Kapustin AN, Shanahan CM. Calcium regulation of vascular smooth muscle cell-derived matrix vesicles. Trends Cardiovasc Med. 2012;22:133-137.
15. Tanimura A, McGregor DH, Anderson HC. Calcifcation in atherosclerosis. I. Human studies. J Exp Pathol. 1986;2:261-273.
16. New SE, Goettsch C, Aikawa M, Marchini JF, Shibasaki M, Yabusaki K, Libby P, Shanahan CM, Croce K, Aikawa E. Macrophage-derived matrix vesicles: an alternative novel mechanism for microcalcifcation in atherosclerotic plaques. Circ Res. 2013;113:72-77.
17. Mauriello A, Sangiorgi GM, Virmani R, Trimarchi S, Holmes DR Jr, Kolodgie FD, Piepgras DG, Piperno G, Liotti D, Narula J, Righini P, Ippoliti A, Spagnoli LG. A pathobiologic link between risk factors pro-fle and morphological markers of carotid instability. Atherosclerosis. 2010;208:572-580.
18. Soor GS, Vukin I, Leong SW, Oreopoulos G, Butany J. Peripheral vascular disease: who gets it and why? A histomorphological analysis of 261 arterial segments from 58 cases. Pathology. 2008;40:385-391.
19. Dhore CR, Cleutjens JP, Lutgens E, Cleutjens KB, Geusens PP, Kitslaar PJ, Tordoir JH, Spronk HM, Vermeer C, Daemen MJ. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 2001;21:1998-2003.
20. Roijers RB, Debernardi N, Cleutjens JP, Schurgers LJ, Mutsaers PH, van der Vusse GJ. Microcalcifcations in early intimal lesions of atherosclerotic human coronary arteries. Am J Pathol. 2011;178:2879-2887.
21. Polak JF, Tracy R, Harrington A, Zavodni AE, O'Leary DH. Carotid artery plaque and progression of coronary artery calcium: the multi-ethnic study of atherosclerosis. J Am Soc Echocardiogr. 2013;26:548-555.
22. Howard DP, van Lammeren GW, Redgrave JN, Moll FL, de Vries JP, de Kleijn DP, de Borst GJ, Pasterkamp G, Rothwell PM. Histological features of carotid plaque in patients with ocular ischemia versus cerebral events. Stroke. 2013;44:734-739.
23. van Lammeren GW, den Hartog AG, Pasterkamp G, Vink A, de Vries JP, Moll FL, de Borst GJ. Asymptomatic carotid artery stenosis: identifcation of subgroups with different underlying plaque characteristics. Eur J Vasc Endovasc Surg. 2012;43:632-636.
24. Friedrich GJ, Moes NY, Mühlberger VA, Gabl C, Mikuz G, Hausmann D, Fitzgerald PJ, Yock PG. Detection of intralesional calcium by intracoronary ultrasound depends on the histologic pattern. Am Heart J. 1994;128:435-441.
25. Burke AP, Weber DK, Kolodgie FD, Farb A, Taylor AJ, Virmani R. Pathophysiology of calcium deposition in coronary arteries. Herz. 2001;26:239-244.
26. Kataoka Y, Wolski K, Uno K, Puri R, Tuzcu EM, Nissen SE, Nicholls SJ. Spotty calcifcation as a marker of accelerated progression of coronary atherosclerosis: insights from serial intravascular ultrasound. J Am Coll Cardiol. 2012;59:1592-1597.
27. Nicholls SJ, Tuzcu EM, Wolski K, Sipahi I, Schoenhagen P, Crowe T, Kapadia SR, Hazen SL, Nissen SE. Coronary artery calcifcation and changes in atheroma burden in response to established medical therapies. J Am Coll Cardiol. 2007;49:263-270.
28. Huang H, Virmani R, Younis H, Burke AP, Kamm RD, Lee RT. The impact of calcifcation on the biomechanical stability of atherosclerotic plaques. Circulation. 2001;103:1051-1056.
29. Motoyama S, Kondo T, Sarai M, Sugiura A, Harigaya H, Sato T, Inoue K, Okumura M, Ishii J, Anno H, Virmani R, Ozaki Y, Hishida H, Narula J. Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol. 2007;50:319-326.
30. Otsuka F, Finn AV, Virmani R. Do vulnerable and ruptured plaques hide in heavily calcifed arteries? Atherosclerosis. 2013;229:34-37.
31. Mauriello A, Servadei F, Zoccai GB, Giacobbi E, Anemona L, Bonanno E, Casella S. Coronary calcifcation identifes the vulnerable patient rather than the vulnerable plaque. Atherosclerosis. 2013;229:124-129.
32. Mintz GS, Pichard AD, Popma JJ, Kent KM, Satler LF, Bucher TA, Leon MB. Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angiographic and intravascular ultrasound study. J Am Coll Cardiol. 1997;29:268-274.
33. Greenland P, Alpert JS, Beller GA, et al; American College of Cardiology Foundation; American Heart Association. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2010;56:e50-103.
34. Raggi P. Prognostic implications of absolute and relative calcium scores. Herz. 2001;26:252-259.
35. Blankstein R, Budoff MJ, Shaw LJ, Goff DC Jr, Polak JF, Lima J, Blumenthal RS, Nasir K. Predictors of coronary heart disease events among asymptomatic persons with low low-density lipoprotein cholesterol MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2011;58:364-374.
36. Joshi PH, Blaha MJ, Blumenthal RS, Blankstein R, Nasir K. What is the role of calcium scoring in the age of coronary computed tomographic angiography? J Nucl Cardiol. 2012;19:1226-1235.
37. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation. 1995;92:2157-2162.
38. Burke AP, Taylor A, Farb A, Malcom GT, Virmani R. Coronary calcifca-tion: insights from sudden coronary death victims. Z Kardiol. 2000;89(suppl 2):49-53.
39. Burke AP, Farb A, Kutys R, Zieske A, Weber D, Virmani R. Atherosclerotic coronary plaques in African Americans are less likely to calcify than coronary plaques in Caucasian Americans. Circulation. 2002;106:II-481. Abstract.
40. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 1990;81:1680-1687.
41. Manson JE, Allison MA, Rossouw JE, et al; WHI and WHI-CACS Investigators. Estrogen therapy and coronary-Artery calcifcation. N Engl J Med. 2007;356:2591-2602.
42. Burke AP, Farb A, Malcom G, Virmani R. Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis. Am Heart J. 2001;141(2 suppl):S58-S62.
43. Bild DE, Detrano R, Peterson D, Guerci A, Liu K, Shahar E, Ouyang P, Jackson S, Saad MF. Ethnic differences in coronary calcifca-tion: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2005;111:1313-1320.
44. Lee TC, O'Malley PG, Feuerstein I, Taylor AJ. The prevalence and severity of coronary artery calcifcation on coronary artery computed tomography in black and white subjects. J Am Coll Cardiol. 2003;41:39-44.
45. Henry YM, Eastell R. Ethnic and gender differences in bone mineral density and bone turnover in young adults: effect of bone size. Osteoporos Int. 2000;11:512-517.
46. Kiel DP, Kauppila LI, Cupples LA, Hannan MT, O'Donnell CJ, Wilson PW. Bone loss and the progression of abdominal aortic calcifcation over a 25 year period: the Framingham Heart Study. Calcif Tissue Int. 2001;68:271-276.
47. Huang CC, Lloyd-Jones DM, Guo X, Rajamannan NM, Lin S, Du P, Huang Q, Hou L, Liu K. Gene expression variation between African Americans and whites is associated with coronary artery calcifcation: the multiethnic study of atherosclerosis. Physiol Genomics. 2011;43:836-843.
48. Fornage M, Boerwinkle E, Doris PA, Jacobs D, Liu K, Wong ND. Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcifcation in African-American subjects: The Coronary Artery Risk Development in Young Adults (CARDIA) study. Circulation. 2004;109:335-339.
49. Sangiorgi G, Rumberger JA, Severson A, Edwards WD, Gregoire J, Fitzpatrick LA, Schwartz RS. Arterial calcifcation and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol. 1998;31:126-133.
50. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med. 1987;316:1371-1375.
51. Burke AP, Kolodgie FD, Farb A, Weber D, Virmani R. Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation. 2002;105:297-303.
52. Wykrzykowska JJ, Mintz GS, Garcia-Garcia HM, Maehara A, Fahy M, Xu K, Inguez A, Fajadet J, Lansky A, Templin B, Zhang Z, de Bruyne B, Weisz G, Serruys PW, Stone GW. Longitudinal distribution of plaque burden and necrotic core-rich plaques in nonculprit lesions of patients presenting with acute coronary syndromes. JACC Cardiovasc Imaging. 2012;5(3 suppl):S10-S18.
53. Rosen BD, Fernandes V, McClelland RL, Carr JJ, Detrano R, Bluemke DA, Lima JA. Relationship between baseline coronary calcium score and demonstration of coronary artery stenoses during follow-up MESA (Multi-Ethnic Study of Atherosclerosis). JACC Cardiovasc Imaging. 2009;2:1175-1183.
54. Speer MY, Giachelli CM. Regulation of cardiovascular calcifcation. Cardiovasc Pathol. 2004;13:63-70.
55. Pai A, Leaf EM, El-Abbadi M, Giachelli CM. Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcifcation in a uremic mouse model of chronic kidney disease. Am J Pathol. 2011;178:764-773.
56. Speer MY, Yang HY, Brabb T, Leaf E, Look A, Lin WL, Frutkin A, Dichek D, Giachelli CM. Smooth muscle cells give rise to osteochon-drogenic precursors and chondrocytes in calcifying arteries. Circ Res. 2009;104:733-741.
57. Giachelli CM. Vascular calcifcation mechanisms. J Am Soc Nephrol. 2004;15:2959-2964.
58. Amizuka N, Hasegawa T, Oda K, Luiz de Freitas PH, Hoshi K, Li M, Ozawa H. Histology of epiphyseal cartilage calcifcation and endochon-dral ossifcation. Front Biosci (Elite Ed). 2012;4:2085-2100.
59. Clarke MC, Littlewood TD, Figg N, Maguire JJ, Davenport AP, Goddard M, Bennett MR. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcifcation and medial degeneration. Circ Res. 2008;102:1529-1538.
60. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL. Apoptosis regulates human vascular calcifcation in vitro: evidence for initiation of vascular calcifcation by apoptotic bodies. Circ Res. 2000;87:1055-1062.
61. Clarke MC, Talib S, Figg NL, Bennett MR. Vascular smooth muscle cell apoptosis induces interleukin-1-directed infammation: effects of hyperlipidemia-mediated inhibition of phagocytosis. Circ Res. 2010;106:363-372.
62. Clarke MC, Figg N, Maguire JJ, Davenport AP, Goddard M, Littlewood TD, Bennett MR. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med. 2006;12:1075-1080.
63. Lutgens E, de Muinck ED, Kitslaar PJ, Tordoir JH, Wellens HJ, Daemen MJ. Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. Cardiovasc Res. 1999;41:473-479.
64. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Kruth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med. 2003;349:2316-2325.
65. Kolodgie FD, Narula J, Burke AP, Haider N, Farb A, Hui-Liang Y, Smialek J, Virmani R. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am J Pathol. 2000;157:1259-1268.
66. Schrijvers DM, De Meyer GR, Kockx MM, Herman AG, Martinet W. Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler Thromb Vasc Biol. 2005;25:1256-1261.
67. Bonetti A, Della Mora A, Contin M, Tubaro F, Marchini M, Ortolani F. Ultrastructural and spectrophotometric study on the effects of putative triggers on aortic valve interstitial cells in in vitro models simulating meta-static calcifcation. Anat Rec (Hoboken). 2012;295:1117-1127.
68. Jian B, Narula N, Li QY, Mohler ER 3rd, Levy RJ. Progression of aortic valve stenosis: TGF-beta1 is present in calcifed aortic valve cusps and promotes aortic valve interstitial cell calcifcation via apoptosis. Ann Thorac Surg. 2003;75:457-465; discussion 465.
69. Naik V, Leaf EM, Hu JH, Yang HY, Nguyen NB, Giachelli CM, Speer MY. Sources of cells that contribute to atherosclerotic intimal calcifcation: an in vivo genetic fate mapping study. Cardiovasc Res. 2012;94:545-554.
70. Reynolds JL, Joannides AJ, Skepper JN, McNair R, Schurgers LJ, Proudfoot D, Jahnen-Dechent W, Weissberg PL, Shanahan CM. Human vascular smooth muscle cells undergo vesicle-mediated calcifcation in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcifcation in ESRD. J Am Soc Nephrol. 2004;15:2857-2867.
71. Karwowski W, Naumnik B, Szczepanski M, Mysliwiec M. The mechanism of vascular calcifcation-A systematic review. Med Sci Monit. 2012;18:RA1-R11.
72. Qiao JH, Mertens RB, Fishbein MC, Geller SA. Cartilaginous metaplasia in calcifed diabetic peripheral vascular disease: morphologic evidence of enchondral ossifcation. Hum Pathol. 2003;34:402-407.
73. Saremi A, Bahn G, Reaven PD; VADT Investigators. Progression of vascular calcifcation is increased with statin use in the Veterans Affairs Diabetes Trial (VADT). Diabetes Care. 2012;35:2390-2392.